Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric K. Rowinsky currently holds 25,844 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric K. Rowinsky has been a net seller of NAVB stock. They have purchased $157.2K and sold $13.4M worth of shares.
Eric K. Rowinsky's most recent insider trade was on Jun 9, 2026, when they sold 1,505 shares at $0.00 per share.
Eric K. Rowinsky serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 85 insider transactions totaling $13.6M over their tenure at the company.
Eric K. Rowinsky holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Eric K. Rowinsky has shown a selling trading pattern, with $157.2K in total purchases and $13.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric K. Rowinsky was on Mar 20, 2015, when they sold $5.5M worth of BIIB shares. This transaction involved 11,667 shares at $475.00 per share.
Eric K. Rowinsky currently owns 25,844 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric K. Rowinsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric K. Rowinsky has 85 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Eric K. Rowinsky and 40,000+ other insiders.